|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:focusesOn
|
precision medicine
drug discovery
genomic medicine
oncology research
small molecule drugs
precision oncology
solid tumors
cancer therapeutics
clinical development
next-generation targeted therapies
oncogenic drivers
tumor resistance mechanisms
|
|
gptkbp:foundedYear
|
2020
|
|
gptkbp:founder
|
gptkb:Gary_D._Glick
|
|
gptkbp:headquartersLocation
|
gptkb:Boston,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Scorpion Therapeutics
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:leader
|
gptkb:Brian_Metcalf_(Chief_Development_Officer)
gptkb:David_Southwell_(Board_Member)
gptkb:Gary_D._Glick_(CEO)
gptkb:Jeff_Albers_(Board_Member)
gptkb:Jennifer_Michaelson_(Chief_Operating_Officer)
gptkb:Keith_Flaherty_(Board_Member)
gptkb:Michael_Meyers_(Chief_Medical_Officer)
Axel Hoos (Chairman)
David Schenkein (Board Member)
Deborah Dunsire (Board Member)
Jean Cui (Chief Scientific Officer)
Lori Kunkel (Board Member)
|
|
gptkbp:notableInvestment
|
gptkb:Abingworth
gptkb:Avidity_Partners
gptkb:BVF_Partners
gptkb:Cowen_Healthcare_Investments
gptkb:EcoR1_Capital
gptkb:Invus
gptkb:Logos_Capital
gptkb:Omega_Funds
gptkb:OrbiMed
gptkb:Perceptive_Advisors
gptkb:Q_Healthcare_Holdings
gptkb:RA_Capital_Management
gptkb:RTW_Investments
gptkb:Redmile_Group
gptkb:Vida_Ventures
gptkb:Polaris_Partners
gptkb:BlackRock
gptkb:Casdin_Capital
gptkb:Atlas_Venture
gptkb:T._Rowe_Price
gptkb:Wellington_Management
gptkb:Cormorant_Asset_Management
gptkb:Janus_Henderson_Investors
gptkb:Surveyor_Capital
gptkb:Woodline_Partners
|
|
gptkbp:pipeline
|
gptkb:STX-101
gptkb:STX-241
gptkb:STX-478
gptkb:STX-721
gptkb:STX-801
|
|
gptkbp:raisesFunding
|
venture capital
|
|
gptkbp:specializesIn
|
targeted cancer therapies
|
|
gptkbp:website
|
https://scorpiontx.com/
|
|
gptkbp:bfsParent
|
gptkb:David_Grayzel
|
|
gptkbp:bfsLayer
|
6
|